risperidone has been researched along with Catatonic Schizophrenia in 12 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We present a case of PPA in catatonic schizophrenia that was successfully treated by switching to aripiprazole from risperidone." | 7.83 | Treatment of Paroxysmal Perceptual Alteration in Catatonic Schizophrenia by Switching to Aripiprazole from Risperidone: A Case Report. ( Horiguchi, J; Ieda, M; Miyaoka, T; Nagahama, M; Tsuchie, K; Wake, R; Yamashita, S, 2016) |
| "A patient with comorbid intellectual disability, catatonic schizophrenia, and recurrent oneiroid state of consciousness improved on long-acting risperidone and remains well at the three-year follow-up." | 7.81 | Effectiveness of long-acting risperidone in a patient with comorbid intellectual disability, catatonic schizophrenia, and oneiroid syndrome. ( Alessi, MC; Angeletti, G; Callovini, G; Criscuolo, S; Del Casale, A; Ferri, VR; Girardi, P; Janiri, D; Kotzalidis, GD; Massolo, AC; Rapinesi, C; Serata, D, 2015) |
| "This case report documents the response of a young, first-episode, neuroleptic naive male with severe catatonic schizophrenia to the novel antipsychotic, risperidone." | 7.70 | Acute and longer-term effects of risperidone in a case of first-episode catatonic schizophrenia. ( Caudle, C; Kopala, LC, 1998) |
| " We present a case of PPA in catatonic schizophrenia that was successfully treated by switching to aripiprazole from risperidone." | 3.83 | Treatment of Paroxysmal Perceptual Alteration in Catatonic Schizophrenia by Switching to Aripiprazole from Risperidone: A Case Report. ( Horiguchi, J; Ieda, M; Miyaoka, T; Nagahama, M; Tsuchie, K; Wake, R; Yamashita, S, 2016) |
| "A patient with comorbid intellectual disability, catatonic schizophrenia, and recurrent oneiroid state of consciousness improved on long-acting risperidone and remains well at the three-year follow-up." | 3.81 | Effectiveness of long-acting risperidone in a patient with comorbid intellectual disability, catatonic schizophrenia, and oneiroid syndrome. ( Alessi, MC; Angeletti, G; Callovini, G; Criscuolo, S; Del Casale, A; Ferri, VR; Girardi, P; Janiri, D; Kotzalidis, GD; Massolo, AC; Rapinesi, C; Serata, D, 2015) |
| "This case report documents the response of a young, first-episode, neuroleptic naive male with severe catatonic schizophrenia to the novel antipsychotic, risperidone." | 3.70 | Acute and longer-term effects of risperidone in a case of first-episode catatonic schizophrenia. ( Caudle, C; Kopala, LC, 1998) |
| "Risperidone treatment was begun (1mg/d and 1." | 1.39 | [Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms]. ( Askenazy, F; Drici, M; Lavrut, T; Menard, ML; Yagoubi, F, 2013) |
| "Tardive seizure is a serious adverse reaction of electroconvulsive therapy (ECT)." | 1.35 | Tardive seizure and antibiotics: case reports and review of the literature. ( Isse, K; Nakamura, M; Saito, T; Watari, M, 2008) |
| " We treated catatonic symptoms with drugs within the upper limit of dosage and electroconvulsive therapy (ECT) to determine the maximal response." | 1.34 | Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms. ( Arai, H; Hatta, K; Miyakawa, K; Nakamura, H; Ota, T; Usui, C, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamashita, S | 1 |
| Miyaoka, T | 2 |
| Nagahama, M | 1 |
| Ieda, M | 1 |
| Tsuchie, K | 1 |
| Wake, R | 1 |
| Horiguchi, J | 2 |
| Serata, D | 1 |
| Rapinesi, C | 1 |
| Kotzalidis, GD | 1 |
| Alessi, MC | 1 |
| Janiri, D | 1 |
| Massolo, AC | 1 |
| Ferri, VR | 1 |
| Criscuolo, S | 1 |
| Callovini, G | 1 |
| Angeletti, G | 1 |
| Girardi, P | 1 |
| Del Casale, A | 1 |
| Saito, T | 1 |
| Nakamura, M | 1 |
| Watari, M | 1 |
| Isse, K | 1 |
| Peitl, MV | 1 |
| Pavlović, E | 1 |
| Peitl, A | 1 |
| Peitl, V | 1 |
| Menard, ML | 1 |
| Yagoubi, F | 1 |
| Drici, M | 1 |
| Lavrut, T | 1 |
| Askenazy, F | 1 |
| Yasukawa, R | 1 |
| Yasuda, H | 1 |
| Hayashida, M | 1 |
| Inagaki, T | 1 |
| Hatta, K | 1 |
| Miyakawa, K | 1 |
| Ota, T | 1 |
| Usui, C | 1 |
| Nakamura, H | 1 |
| Arai, H | 1 |
| Dhossche, D | 1 |
| Petrides, G | 1 |
| Poyurousky, M | 1 |
| Bergman, J | 1 |
| Weizman, A | 1 |
| Kopala, LC | 1 |
| Caudle, C | 1 |
| Takahashi, H | 1 |
| Hesslinger, B | 1 |
| Walden, J | 1 |
| Normann, C | 1 |
12 other studies available for risperidone and Catatonic Schizophrenia
| Article | Year |
|---|---|
Treatment of Paroxysmal Perceptual Alteration in Catatonic Schizophrenia by Switching to Aripiprazole from Risperidone: A Case Report.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Drug Substitution; Humans; Male; Perceptual Disorders; Qu | 2016 |
Effectiveness of long-acting risperidone in a patient with comorbid intellectual disability, catatonic schizophrenia, and oneiroid syndrome.
Topics: Adult; Ambroxol; Antipsychotic Agents; Brain; Dreams; Follow-Up Studies; Humans; Intellectual Disabi | 2015 |
Tardive seizure and antibiotics: case reports and review of the literature.
Topics: Anti-Bacterial Agents; Antipsychotic Agents; Electroconvulsive Therapy; Electroencephalography; Huma | 2008 |
Amenorrhoea - consequence of combined treatment with sulpiride and risperidone in a patient suffering from schizophrenia.
Topics: Amenorrhea; Antipsychotic Agents; Drug Therapy, Combination; Female; Humans; Hyperprolactinemia; Mid | 2010 |
[Follow-up of a 16-year-old adolescent with early-onset schizophrenia and catatonic symptoms].
Topics: Adolescent; Benzodiazepines; Carbamazepine; Clonazepam; Clozapine; Creatine Kinase; Diagnosis, Diffe | 2013 |
Possible antipsychotic effects of minocycline in patients with schizophrenia.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Antipsychotic Agents; Electroencephalography; Haloperid | 2007 |
Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms.
Topics: Administration, Oral; Adult; Aged; Antipsychotic Agents; Catatonia; Diazepam; Dose-Response Relation | 2007 |
Negative symptoms or catatonia?
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Benzodiazepinones; Child; Clobazam; Cloz | 1997 |
Risperidone in the treatment of catatonia in a schizophrenic patient.
Topics: Antipsychotic Agents; Humans; Male; Middle Aged; Risperidone; Schizophrenia, Catatonic | 1997 |
Acute and longer-term effects of risperidone in a case of first-episode catatonic schizophrenia.
Topics: Adolescent; Antipsychotic Agents; Humans; Male; Movement Disorders; Psychiatric Status Rating Scales | 1998 |
Acute dystonia induced by adding midodrine, a selective alpha 1 agonist, to risperidone in a patient with catatonic schizophrenia.
Topics: Acute Disease; Adrenergic alpha-Agonists; Adult; Antipsychotic Agents; Dystonia; Female; Humans; Mid | 2000 |
Acute and long-term treatment of catatonia with risperidone.
Topics: Acute Disease; Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Long-Term Care; Male; | 2001 |